SUVEN LIFE SCIENCES
Back to Income Statement
|
SUVEN LIFE SCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-105 Cr | ₹-118 Cr | ₹-122 Cr | ₹-72 Cr | ₹-94 Cr |
What is the latest Consolidated Net Profit of SUVEN LIFE SCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-105 Cr |
| Mar2024 | ₹-118 Cr |
| Mar2023 | ₹-122 Cr |
| Mar2022 | ₹-72 Cr |
| Mar2021 | ₹-94 Cr |
How is Consolidated Net Profit of SUVEN LIFE SCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-105 Cr | Negative | |
| Mar2024 | ₹-118 Cr | Negative | |
| Mar2023 | ₹-122 Cr | Negative | |
| Mar2022 | ₹-72 Cr | Negative | |
| Mar2021 | ₹-94 Cr | - | |
Compare Consolidated Net Profit of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹9,646.6 Cr | -4.7% | 26.3% | 35.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -4.7% |
26.3% |
35.8% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses